Skip to content
CLBT

Cellebrite DI Ltd.

Cellebrite DI Ltd. Q3 FY2024 earnings call

November 6, 2024 · fiscal period ended 2024-09

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2024-11-06

Management highlights

  • Strong Q3 performance with ARR growth, $100M quarterly revenue, and outstanding profitability.
  • Strategic actions include launching Cellebrite Federal Solutions, augmenting sales force, and focusing on Insights upgrade with 15% adoption target for 2024.
  • Four strategic priorities: extend leadership in digital forensic units, accelerate growth in investigative/intelligence units, expand private sector business, and help customers harness cloud.
  • Cloud investments with Pathfinder in the cloud announced, and Guardian seeing traction in international markets.
View in transcript ↓

Segment performance

Cellebrite's ARR grew 26% year-on-year to $371 million at the end of September 2024. The Insights suite drove the majority of ARR growth, complemented by Guardian and Pathfinder. Third quarter revenue was $106.8 million, the first time exceeding $100 million, with a 27% year-on-year growth. Subscription revenue represented approximately 87% of total revenue. Geographically, Americas accounted for 54% of ARR, EMEA 34%, and APAC 12%.

View in transcript ↓

Guidance

  • Raised 2024 revenue range to $397 million to $401 million, adjusted EBITDA to $96 million to $100 million, and ARR low end to $390 million.
  • Fourth quarter revenue expected to be between $105 million and $109 million, adjusted EBITDA between $25 million and $29 million.
  • Anticipates solid ARR expansion and profitability in 2025 to meet or exceed Rule of 45 baseline.
View in transcript ↓

Risks

Forward-looking statements subject to risks and uncertainties as outlined in the company's annual report on Form 20-F filed with the SEC, including factors that could cause actual results to differ from forward-looking statements.

View in transcript ↓

Q&A highlights

Q: Shaul Eyal asked about CEO location and CyTech acquisition contribution.

A: Thomas Hogan said search is wide open geographically; Dana Gerner said CyTech contribution this quarter was slightly below $0.5 million.

Q: Mike Cikos asked about CEO search progress and long-term models.

A: Thomas Hogan said no fundamental change to business plan; search firms are building candidate slate.

Q: Jeffrey Van Rhee asked about Insights adoption and unlock trends.

A: Yossi Carmil and Dana Gerner discussed Insights adoption potential and unlocks driving ARPU uplift.

Q: Brian Essex asked about CEO transition criteria.

A: Thomas Hogan said search has wide aperture, focusing on best leader regardless of specific criteria.

Q: Jonathan Ho asked about net retention and AI leverage.

A: Dana Gerner talked about ARR growth from expansion; Yossi Carmil discussed AI's role in investigative speed and efficiency.

Q: Tomer Zilberman asked about government budgets.

A: Yossi Carmil said federal and state/local budgets performed as expected with no impact from administration changes.

Q: Max Michaels asked about EBITDA and pro services.

A: Dana Gerner explained EBITDA expectations and pro services related to an APAC customer.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

November 6, 2024

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.